Medical supervised duodenal-enteral feeding for the treatment of overweight and obesity: MESUDEFT / Nutrición duodenoenteral médicamente supervisada para el tratamiento del sobrepeso y la obesidad: MESUDEFT

Background: the development of specialised nutritional support techniques allows the maintenance of an adequate supply of nutrients in those patients in whom oral feeding is not possible or is insufficient in relation to their requirements, trying to improve the quality of life, especially in those with chronic diseases. Methods: single-center clinical study carried out in a clinical-nutritional center consisting of a medically supervised nasogastric-duodenal tube feeding treatment for overweight, obesity and increased body fat percentage in patients requiring it by means of duodeno-enteral feeding, expecting losses of more than 10 %. Results: twenty-nine patients completed the protocol (20.4 % male and 79.6 % female) with a mean age of 38 years (SD: 12.4); 87.2 kg (SD: 18.5) mean weight; 37.9 kg (SD: 4.8) mean iFat%; 32.4 (SD: 5.4) iMean body mass index (BMI); 100 cm (SD: 16.0) iMean waist; 113.6 cm (SD: 10.4) iMean hip; 33.8 cm (SD: 3.9) iMean upper arm circumference; 65.5 cm (SD: 7.5) iMean thigh circumference; 9.7 (SD: 4.8) iVisceral fat index; and 22.9 days (SD: 13.9) mean treatment. A mean of 22.9 (SD: 13.9) days of MESUDEFT influences weight loss, fat loss, visceral fat loss and decreased arm, hip and thigh circumferences (p < 0.05) (i: initial). Conclusions: MESUDEFT is shown to be an effective alternative as a sole treatment or as an adjunct prior to bariatric surgery for obesity or overweight treatment with a minimum of 10 % loss of BMI and fat mass at completion and 3-6 months follow-up.(AU)

Antecedentes: el desarrollo de técnicas especializadas de soporte nutricional permite mantener un aporte adecuado de nutrientes en aquellos pacientes en los que la alimentación oral no es posible o es insuficiente en relación a sus requerimientos, intentando mejorar la calidad de vida, especialmente de aquellos con enfermedades crónicas. Métodos: estudio clínico unicéntrico prospectivo realizado en un centro clínico-nutricional consistente en un tratamiento con alimentación por sonda nasogástrica-duodenal médicamente supervisado para el sobrepeso, la obesidad y el aumento del porcentaje de grasa corporal en pacientes que lo requieran mediante alimentación duodenoenteral, durante un mes aproximado, con previsión de pérdidas superiores al 10 % y con control posterior entre los tres y los seis meses siguientes. Resultados: veintinueve pacientes completaron el protocolo (20,4 % varones y 79,6 % mujeres) con una edad media de 38 años (DE: 12,4); 87,2 kg (DE: 18,5) iPeso medio; 37,9 kg (DE: 4,8) iGrasa% media; 32,4 (DE: 5,4) iIMC medio; 100 cm (DE: 16,0) iCintura media; 113,6 cm (DE: 10,4) iCadera media; 33,8 cm (DE: 3,9) iCircunferencia braquial media; 65,5 cm (DE: 7,5) circunferencia muslo media; 9,7 (DE: 4,8) iíndice de grasa visceral; y 22,9 días (DE: 13,9) de tratamiento medio. Una media de 22,9 (DE: 13,9) días de MESUDEFT influye en la pérdida de peso, la pérdida de grasa, la pérdida de grasa visceral y la disminución de las circunferencias del brazo, la cadera y el muslo (p < 0,05) (i: inicial). Conclusiones: MESUDEFT se muestra como una alternativa eficaz como tratamiento único o como coadyuvante previo a la cirugía bariátrica de la obesidad o tratamiento del sobrepeso con una pérdida mínima del 10 % del índice de masa corporal (IMC) y de la masa grasa al finalizar y con control durante los siguientes 3-6 meses.(AU)

Defective mitochondria remodelling in B cells leads to an aged immune response.

The B cell response in the germinal centre (GC) reaction requires a unique bioenergetic supply. Although mitochondria are remodelled upon antigen-mediated B cell receptor stimulation, mitochondrial function in B cells is still poorly understood. To gain a better understanding of the role of mitochondria in B cell function, here we generate mice with B cell-specific deficiency in Tfam, a transcription factor necessary for mitochondrial biogenesis. Tfam conditional knock-out (KO) mice display a blockage of the GC reaction and a bias of B cell differentiation towards memory B cells and aged-related B cells, hallmarks of an aged immune response. Unexpectedly, blocked GC reaction in Tfam KO mice is not caused by defects in the bioenergetic supply but is associated with a defect in the remodelling of the lysosomal compartment in B cells. Our results may thus describe a mitochondrial function for lysosome regulation and the downstream antigen presentation in B cells during the GC reaction, the dysruption of which is manifested as an aged immune response.

Medical supervised duodenal-enteral feeding for the treatment of overweight and obesity: MESUDEFT.

BACKGROUND: the development of specialised nutritional support techniques allows the maintenance of an adequate supply of nutrients in those patients in whom oral feeding is not possible or is insufficient in relation to their requirements, trying to improve the quality of life, especially in those with chronic diseases. METHODS: single-center clinical study carried out in a clinical-nutritional center consisting of a medically supervised nasogastric-duodenal tube feeding treatment for overweight, obesity and increased body fat percentage in patients requiring it by means of duodeno-enteral feeding, expecting losses of more than 10 %. RESULTS: twenty-nine patients completed the protocol (20.4 % male and 79.6 % female) with a mean age of 38 years (SD: 12.4); 87.2 kg (SD: 18.5) mean weight; 37.9 kg (SD: 4.8) mean iFat%; 32.4 (SD: 5.4) iMean body mass index (BMI); 100 cm (SD: 16.0) iMean waist; 113.6 cm (SD: 10.4) iMean hip; 33.8 cm (SD: 3.9) iMean upper arm circumference; 65.5 cm (SD: 7.5) iMean thigh circumference; 9.7 (SD: 4.8) iVisceral fat index; and 22.9 days (SD: 13.9) mean treatment. A mean of 22.9 (SD: 13.9) days of MESUDEFT influences weight loss, fat loss, visceral fat loss and decreased arm, hip and thigh circumferences (p < 0.05) (i: initial). CONCLUSIONS: MESUDEFT is shown to be an effective alternative as a sole treatment or as an adjunct prior to bariatric surgery for obesity or overweight treatment with a minimum of 10 % loss of BMI and fat mass at completion and 3-6 months follow-up.

Neurosurgery Morbidity and Mortality: A Prospective Surgical and Medical Analysis.

OBJECTIVE: The analysis of morbidity and mortality is fundamental for improving the quality of patient care. The objective of this study was to evaluate the combined medical and surgical morbidity and mortality of neurosurgical patients. METHODS: We performed a daily prospective compilation of morbidities and mortalities during a consecutive 4-month period in all the patients who were 18 years of age or older and had been admitted to the neurosurgery service at the Puerto Rico Medical Center. For each patient, any surgical or medical complication, adverse event, or death within 30 days was included. The patients' comorbidities were analyzed for their influence on mortality. RESULTS: Fifty-seven percent of the patients presented at least 1 complication. The most frequent complications were hypertensive episodes, mechanical ventilation for more than 48 hours, sodium disturbances, and bronchopneumonia. Twenty-one patients died, for an overall 30-day mortality of 8.2%. Mechanical ventilation for more than 48 hours, sodium disturbances, bronchopneumonia, unplanned intubation, acute kidney injury, blood transfusion, shock, urinary tract infection, cardiac arrest, arrhythmia, bacteremia, ventriculitis, sepsis, elevated intracranial pressure, vasospasm, stroke, and hydrocephalus were significant factors for mortality. None of the analyzed patients' comorbidities were significant for mortality or longer length of stay. The type of surgical procedure did not influence the length of stay. CONCLUSION: The mortality and morbidity analysis provided valuable neurosurgical information that may influence future treatment management and corrective recommendations. Indication and judgment errors were significantly associated with mortality. In our study, the patients' comorbidities were not significant for mortality or increased length of stay.

Dataset for estimation of muscle Dysmorphia in individuals from Colombia.

This paper presents data collected through a questionnaire for the estimation of body dysmorphic disorder known as vigorexy, weight level and levels of exercise dependence in individuals from Barranquilla, Colombia who attend local gyms, based on their physical activity, food supplements eating habits, psychological pressure, and risk of muscle dysmorphia. The Data contains 8 tributes and 200 records; labelling obesity range according to WHO into normal, overweight or obesity. All data was collected in person and directly from users. This data can be used to generate scientific research and intelligent computational tools to identify the obesity level and muscle dysmorphia risk of an individual and to build recommender systems that monitor health and mental status.

Epidemiology and etiology of secondary piriformis syndrome: A single-institution retrospective study.

Piriformis syndrome (PS) is a rare etiology of extra-spinal sciatica in which pathologies associated with or around the piriformis muscle (PM) irritate the adjacent sciatic nerve (SN), however, there is scarcity in the literature regarding its exact etiologies, thus, we performed a retrospective study to elucidate the epidemiology of PS and assess various causes of the syndrome. Our study included patients assessed at our institution who presented with sciatica of non-spinal origin between May 2014 and December 2015. Radiology reports of all patients who received pelvic MRI were examined for positive findings involving PM and SN. Of the 143 patients recognized with sciatica and negative lumbar pathology, 24 patients (17%) exhibited positive PM and SN findings. Average patient age was 50.0 ±â€¯15.1 years (range: 21-75), and 17 were female. Seven patients (5%; 4M/3F) presented with tumor, seven patients (5%) had chronic inflammatory changes, one patient had SN adhesions to obturator muscle, three patients (2%, 3F) had aberrant anatomy, and the remaining patients had positive MRI findings, such as nerve atrophy or PM hypertrophy without identifiable cause. Seven patients received steroid injections in the peri-sciatic fossa, and four displayed poor response. Our findings suggested possible trends in extra-spinal sciatica. Affected males appeared more likely to present with tumor, while affected females were more likely to present younger, but with aberrant anatomy. Steroid injections appeared to be suboptimal in most cases. Pelvic MRI is helpful in patients with sciatica and negative spine imaging to rule out neoplastic involvement.

Atención Psicoprofiláctica a la Mujer embarazada / Psychoprophylactic care of the pregnant woman

Se expone la experiencia obtenida en la atención psicológica a la mujer embarazada en el regional Cienfuegos. Se explican los métodos utilizados para la preparación psíquica de la embarazada: 1. Grupo educativo-terapéutico a partir de 5to. mes de embarazo y cuya duración es de un mes, compartiéndose en cuatro sesiones, una semanal. 2. Hipnosis, concebida en su modalidad recuperadora y tranquilizante, utilizándose sugerencias poshipnóticas de gran ayuda a la paciente en el parto. Se considera que los resultados muestran la efectividad de los métodos utilizados, ya que la casi totalidad de las embarazadas tratadas han presentado una conducta significativamente tranquila, optimista, actitud concentrada y cooperación durante todo el proceso de parto. Igualmente se plantea como aspecto de inestimable valor para la preparación integral de la mujer embarazada y parturienta el trabajo técnico en equipo formado por especialistas (tocólogos, pediatras, psicólogos, enfermeras, cinesiólogos) con fines preventivos y de investigación(AU)